BR9811086A - Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica - Google Patents

Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica

Info

Publication number
BR9811086A
BR9811086A BR9811086-1A BR9811086A BR9811086A BR 9811086 A BR9811086 A BR 9811086A BR 9811086 A BR9811086 A BR 9811086A BR 9811086 A BR9811086 A BR 9811086A
Authority
BR
Brazil
Prior art keywords
pharmaceutical
production
erythropoietin
combination preparation
unit packaging
Prior art date
Application number
BR9811086-1A
Other languages
English (en)
Inventor
Paul Lehmann
Joachim Peter Kaltwasser
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of BR9811086A publication Critical patent/BR9811086A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

<B><MU>UTILIZAçãO DE PREPARADOS DE ERITROPOIETINA E FERRO, PROCESSO PARA A PRODUçãO DE UM PREPARADO DE COMBINAçãO FARMACêUTICA E EMBALAGEM UNITáRIA FARMACêUTICA<MV><D> A invenção refere-se à utilização de formas de administração únicas de um preparado de eritropoietina e de um preparado de ferro fisiologicamente adequado, correspondente a uma quantidade equivalente de 1-40 mg de íons de ferro, para produzir um preparado de combinação farmacêutica para o tratamento de doenças reumáticas.
BR9811086-1A 1997-08-08 1998-08-05 Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica BR9811086A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19734293A DE19734293A1 (de) 1997-08-08 1997-08-08 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
PCT/EP1998/004864 WO1999007401A2 (de) 1997-08-08 1998-08-05 Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen

Publications (1)

Publication Number Publication Date
BR9811086A true BR9811086A (pt) 2000-08-29

Family

ID=7838328

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811086-1A BR9811086A (pt) 1997-08-08 1998-08-05 Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica

Country Status (15)

Country Link
US (1) US6372715B1 (pt)
EP (1) EP1037648B1 (pt)
JP (3) JP2001513510A (pt)
KR (1) KR100478573B1 (pt)
CN (1) CN1170589C (pt)
AT (1) ATE263571T1 (pt)
AU (1) AU738027B2 (pt)
BR (1) BR9811086A (pt)
CA (1) CA2297959C (pt)
DE (2) DE19734293A1 (pt)
DK (1) DK1037648T3 (pt)
ES (1) ES2218851T3 (pt)
PT (1) PT1037648E (pt)
TR (1) TR200000369T2 (pt)
WO (1) WO1999007401A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222118T1 (de) * 1997-03-18 2002-08-15 Roche Diagnostics Gmbh Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
WO2001087329A1 (en) * 2000-05-15 2001-11-22 F. Hoffmann-La Roche Ag Liquid pharmaceutical composition containing an erythropoietin derivate
CN1473265B (zh) * 2000-11-02 2011-10-12 色品先进技术股份有限公司 生产纯化的补血铁-糖复合物的方法及产品的生产
US6929954B2 (en) * 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
CN100528235C (zh) 2000-12-20 2009-08-19 霍夫曼-拉罗奇有限公司 红细胞生成素共轭物
EP1909106B1 (en) 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
WO2006084782A1 (de) * 2005-02-09 2006-08-17 Vifor (International) Ag Verwendung von eisen(iii)-komplexverbindungen
NZ591701A (en) * 2005-05-16 2012-11-30 Abbott Biotech Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
WO2007120656A2 (en) * 2006-04-10 2007-10-25 Abbott Biotechnology Ltd. Uses and compositions for treatment of rheumatoid arthritis
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
CA2659990C (en) 2006-08-04 2016-03-22 Prolong Pharmaceuticals, Inc. Polyethylene glycol erythropoietin conjugates
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
MX2010010503A (es) * 2008-03-24 2010-11-09 Abbott Biotech Ltd Metodos y composiciones para tratar perdida osea.
US8202830B2 (en) 2009-01-30 2012-06-19 Ecolab Usa Inc. Development of an aluminum hydroxydicarboxylate builder
CN102292428B (zh) * 2009-01-30 2014-06-04 埃科莱布有限公司 羟基羧酸铝助洗剂的开发
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
JP6085401B2 (ja) * 2014-07-25 2017-02-22 原　和弘 薬剤投与情報提供装置及び薬剤投与情報提供のためのコンピュータプログラム
SI3380487T1 (sl) 2015-11-23 2020-11-30 Bristol-Myers Squibb Company Sistemi dodatkov za uporabo pri pegilaciji proteinov

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194947A (en) * 1979-09-18 1983-06-14 C Holland Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
EP0784480B1 (en) * 1994-11-03 2003-10-15 Boehringer Mannheim Gmbh Use of erythropoietin in the treatment of rheumatoid arthritis
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen

Also Published As

Publication number Publication date
AU738027B2 (en) 2001-09-06
TR200000369T2 (tr) 2000-09-21
ES2218851T3 (es) 2004-11-16
KR20010022738A (ko) 2001-03-26
CA2297959C (en) 2011-11-29
JP2001513510A (ja) 2001-09-04
DE19734293A1 (de) 1999-02-11
PT1037648E (pt) 2004-08-31
EP1037648B1 (de) 2004-04-07
EP1037648A2 (de) 2000-09-27
US6372715B1 (en) 2002-04-16
JP2012012410A (ja) 2012-01-19
AU9159098A (en) 1999-03-01
CN1170589C (zh) 2004-10-13
JP2008133290A (ja) 2008-06-12
ATE263571T1 (de) 2004-04-15
WO1999007401A2 (de) 1999-02-18
WO1999007401A3 (de) 1999-04-29
DK1037648T3 (da) 2004-08-02
DE59811158D1 (de) 2004-05-13
CA2297959A1 (en) 1999-02-18
KR100478573B1 (ko) 2005-03-28
CN1268058A (zh) 2000-09-27

Similar Documents

Publication Publication Date Title
BR9811086A (pt) Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
BR0015188A (pt) Composições farmacêuticas
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
AR032293A1 (es) Estuche farmaceutico
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
SE8901003L (sv) Snabbloesliga preparat
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.